NTR2

NTR2 (Neurotensin Receptor 2, NTSR2) is a G protein-coupled receptor that mediates neurotensin-dependent neuropeptide signaling and participates in cell-surface receptor signaling pathways.^[1] Mechanistically, NTR2 is linked to phosphatidylinositol-calcium second-messenger signaling, supporting its role in neuronal and peripheral physiological regulation.^[2] Neurotensin signaling has been implicated in neurotransmission, stress-related responses, nociception, and neuropsychiatric processes, providing an important biological context for studies of NTR2 function.^[5] In disease-associated models, altered NTR2 expression has been reported in chronic lymphocytic leukemia, prostate cancer, and other malignancies, indicating that dysregulated NTR2 signaling may contribute to tumor-related cellular phenotypes.^[1][3] Compared with the closely related isoform NTR1, NTR2 exhibits lower affinity for neurotensin and distinct pharmacological properties despite substantial sequence homology between the receptors.^[4][6] NTR2 is also selectively recognized by levocabastine, a characteristic frequently used to distinguish NTR2-mediated responses from NTR1-dependent signaling in experimental systems.^[4][6] Furthermore, evidence suggests that NTR2 can regulate NTR1 activity through receptor cross-talk, resulting in intracellular sequestration and functional inhibition of NTR1 under specific conditions.^[1] For experimental applications, selective ligands, including levocabastine-sensitive compounds and receptor-targeting pharmacological tools, are commonly employed to dissect NTR2-specific signaling mechanisms and receptor biology.^[4]

References: